messag mondelez finish year strong result full year organ
sale growth exceed manag guidanc
estim thank strong global categori growth market share gain think
manag right thing invest growth across portfolio think
manag new sale growth guidanc conserv year
adjust ep estim prev unchang
introduc estim rais price target prev
due lower year-end net debt balanc ev calcul
mondelez report especi strong finish year organ sale growth
beat estim thank primarili stronger volum growth north
america full year organ sale growth also well origin
guidanc manag provid late gross margin in-lin
year-ago ahead estim bp mostli off-set higher sg
spend ep beat estim due slightli higher oper incom
benefit lower interest expens off-set higher tax rate manag introduc
guidanc target result in-lin long-term
target top line high-singl digit growth ep remain posit
mondelez think best-in-class food compani like organ
shift prioriti growth brand reinvest away year hyper-focu
margin expans continu see clear proof progress good momentum
especi us compani focus altern channel build
conservat manag provid guidanc organ sale growth
in-lin expect long-term growth target
organ growth rate think target emb conservat
manag said global categori acceler
mondelez took held share snack portfolio drive bp
out-performance challeng manag expect global categori
return normal growth rate due last year prolong easter sell
season benefit lap hotter summer europ conserv
assum anoth bp growth come market share gain arriv
organ growth estim alreadi assum pressur china
sale due coronaviru
invest brand take market share compani spent increment
market manag said expect spend anoth
invest go work media across geographi route-
to-market capabl emerg market support on-going global market share
gain model bp gross margin expans driven larg brazil
suppli chain issu longer creat drag gross profit dollar increas
help fund higher spend year net expect oper margin
expand bp
long-term option longer term think appropri contempl action
mondelez could take futur order sustain push top-lin growth algorithm
competit mid-single-digit grower nestl nesn-
ch ko trade premium valuat view
compani consider option go forward includ monet
stake keurig dr pepper and/or stake jacob douw egbert fund
potenti acquisit especi intern see detail short term
manag said divestitur non-cor asset gum candi unlik
would reduc scale certain market would financi viabl unless
snack acquisit made concurr help off-set loss scale
page analyst certif import disclosur
manag provid growth guidanc behind pace top line
line long-term target detail front page view organ
growth guidanc conserv emb manag expect slower global
categori growth like cushion brexit coronaviru concern model
organ sale growth constant-curr fx growth
figur guidanc in-lin long-term growth target
page analyst certif import disclosur
valuat risk
previous price target assum blend price-to-earnings multipl ev/ebitda
multipl earn price-to-earnings repres premium food coverag
trade around price-to-earnings given higher expect organ sale growth compound-annual-growth-rate ep growth
estim versu food peer intern sale exposur especi emerg
market favor categori exposur option associ coffe
risk valuat
risk downsid includ
global recess current uncertainti market chanc global
recess like sale slowdown start observ throughout
world compani high intern exposur close would
neg impact compani sale
us gum declin continu although compani announc specif initi
help revers gum declin uncertainti abl could
limit organ sale growth entir compani gum profit
categori compani margin expans could limit result
privat label privat label alreadi neg impact mani compani
categori continu grow may continu pace faster
expect allow privat label rapidli take share mani compani
categori limit sale expans
page analyst certif import disclosur
page analyst certif import disclosur
incom million except per emar y-o-i growth na cost good gross gross sell gener expens total oper sg oper oper y-o-i growth na ebitda y-o-i growth na net interest incom incom tax non-control incom adj dilut y-o-i growth dilut share sale breakdownvolum acquisit extra week net sale organ food produc
issu research report guggenheim secur llc guggenheim secur research analyst whose name appear report
herebi certifi view express report accur reflect research analyst person view subject
secur issuer discuss herein ii part research analyst compens directli indirectli relat specif
recommend view express research analyst
research analyst whose name appear report receiv compens base upon variou factor includ qualiti research
investor client feedback guggenheim secur llc overal revenu includ invest bank revenu
guggenheim secur llc affili expect receiv intend seek compens invest bank servic mondelez
inc next month
pleas refer websit company-specif disclosur referenc report http //guggenheimsecur bluematrix com/sellside/
disclosur action disclosur inform also avail complianc madison avenu new york ny
rate price target histori inc
creat bluematrix
buy describ stock expect provid total return price appreci plu yield within period
neutral describ stock expect provid total return price appreci plu yield plu minu within
sell describ stock expect provid total neg return price appreci plu yield within period
nr invest rate price target temporarili suspend suspens complianc applic regul and/or
cs coverag suspend guggenheim secur llc suspend coverag compani
nc cover guggenheim secur llc cover compani
monitor describ stock whose compani fundament financi monitor financi project opinion
invest merit compani provid
review ur follow releas signific news compani rate temporarili place review suffici
inform obtain assess analyst
guggenheim secur llc methodolog assign rate may includ follow market capit matur growth/valu volatil
expect total return next month price target base sever methodolog may includ restrict analys
market risk growth rate revenu stream discount cash flow dcf ebitda ep cash flow cf free cash flow ev/ebitda price-to-earnings pe/growth
price-to-cf p/fcf premium discount /averag group ev/ebitda premium discount /averag group price-to-earnings sum part net asset valu dividend return
return equiti roe next month
price target assign buy- sell-rat stock price target neutral-r stock provid discret analyst
page analyst certif import disclosur
